PET hypoxia imaging with FAZA: reproducibility at baseline and during fractionated radiotherapy in tumour-bearing mice.
about
The impact of hypoxia and its modification of the outcome of radiotherapyValidation of functional imaging as a biomarker for radiation treatment responsePositron Emission Tomography for the Response Evaluation following Treatment with Chemotherapy in Patients Affected by Colorectal Liver Metastases: A Selected ReviewPositron emission tomography to assess hypoxia and perfusion in lung cancerPET Metabolic Biomarkers for CancerPET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidenceEvaluation of repeated [(18)F]EF5 PET/CT scans and tumor growth rate in experimental head and neck carcinomas18F-EF5 PET Is Predictive of Response to Fractionated Radiotherapy in Preclinical Tumor ModelsRepeatability of hypoxia PET imaging using [¹⁸F]HX4 in lung and head and neck cancer patients: a prospective multicenter trialLongitudinal tumor hypoxia imaging with [(18)F]FAZA-PET provides early prediction of nanoliposomal irinotecan (nal-IRI) treatment activity.The diagnostic value of 99TcM-2-(2-methyl-5-nitro-1H-imidazol-1-yl) ethyl dihydrogen phosphate hypoxia imaging and its evaluation performance for radiotherapy efficacy in non-small-cell lung cancer.In vivo quantification of hypoxic and metabolic status of NSCLC tumors using [18F]HX4 and [18F]FDG-PET/CT imaging.Molecular imaging of hypoxia in non-small-cell lung cancer.FMISO as a Biomarker for Clinical Radiation Oncology.Cell inactivation by combined low dose-rate irradiation and intermittent hypoxia.Carbon ion radiotherapy: impact of tumor differentiation on local control in experimental prostate carcinomas.Repeatability of tumour hypoxia imaging using [18F]EF5 PET/CT in head and neck cancer.Imaging the Tumor Microenvironment.Hypoxia-guided adaptive radiation dose escalation in head and neck carcinoma: a planning study.A prospective clinical study of ¹⁸F-FAZA PET-CT hypoxia imaging in head and neck squamous cell carcinoma before and during radiation therapy.Hypoxia imaging with 18F-FAZA PET/CT predicts radiotherapy response in esophageal adenocarcinoma xenografts.
P2860
Q26779537-8775F747-4C1C-4572-8717-9E0495134049Q26823165-33467FCC-7B5A-4096-B4CE-CA25A148767DQ27009240-790F3C19-044C-4169-87ED-7B75967F9528Q27026940-1E1B8266-E83A-453D-B437-9D7AFEFB6FFCQ28074449-1ECF9DAF-75DE-4622-82FA-7488518642A1Q33818999-324008B5-E80A-4C10-82A2-46FE8C919C36Q35545964-DC57F742-10C8-4494-AC99-1CB6378A94E1Q35797158-5B49ED21-9265-4332-B9C7-BD7403B9BB2FQ36109283-1EBBE7ED-02DB-4F74-811E-B05894F91789Q36177290-0FCF5411-90C1-450C-88F6-8D3CC7924276Q37376784-D8E1244C-90CD-419E-8949-7B1FBDB4D302Q37581964-E721FE12-C384-45ED-A93D-D924A7BEF27EQ38363234-C0334590-CCBD-4CF1-BB36-ED9C6D6998CEQ38869449-22435AB1-3870-4572-80EF-8DA6C9AD040DQ38928457-CA9361CD-4CE9-445F-A683-0A9E2E814E22Q47100339-DAD2C54F-B622-44E2-A9D5-3101EF2F7613Q47707479-75BEAC8E-B435-467E-8A1F-DEFC99887523Q49592815-A157398E-D5CB-4A2F-8FB2-777007036548Q53032114-B4D9589C-3231-4768-92F1-AFC87ABCCBA5Q53077788-E059BEF6-556E-4649-B4B3-0799D8C2AB34Q55046912-6D8CC84F-00E9-4589-B548-669A2598C994
P2860
PET hypoxia imaging with FAZA: reproducibility at baseline and during fractionated radiotherapy in tumour-bearing mice.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
PET hypoxia imaging with FAZA: ...... herapy in tumour-bearing mice.
@en
PET hypoxia imaging with FAZA: ...... herapy in tumour-bearing mice.
@nl
type
label
PET hypoxia imaging with FAZA: ...... herapy in tumour-bearing mice.
@en
PET hypoxia imaging with FAZA: ...... herapy in tumour-bearing mice.
@nl
prefLabel
PET hypoxia imaging with FAZA: ...... herapy in tumour-bearing mice.
@en
PET hypoxia imaging with FAZA: ...... herapy in tumour-bearing mice.
@nl
P2093
P2860
P921
P1476
PET hypoxia imaging with FAZA: ...... herapy in tumour-bearing mice.
@en
P2093
F P D'Andrea
J F Kallehauge
J Overgaard
K V Hansen
L S Mortensen
M Nordsmark
M R Horsman
S Jakobsen
P2860
P2888
P304
P356
10.1007/S00259-012-2258-X
P577
2012-10-18T00:00:00Z